Terms ending in 2027
Every in-force patent on The Institut Pasteur's record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,222,029 | A Lentiviral Vector-Based Vaccine Institut Pasteur, Centre National de la Recherche Scientifique and Institut National de la Sante et de la Recherche Medicale In force · High confidence | Institut Pasteur, Centre National de la Recherche Scientifique and Institut National de la Sante et de la Recherche Medicale | In force | High confidence | |
| US 7,736,850 | Novel Strain of SARS-Associated Coronavirus and Applications Thereof In force · High confidence | Institut Pasteur, Centre National de la Recherche Scientifique and Universite Paris 7 | In force | High confidence | |
| US 10,767,167 | Polynucleotides Encoding MHC Class I-Restricted Htert Epitopes, Analogues Thereof or Polyepitopes In force · High confidence | Inserm (Institut National de la Sante et de la Recherche Medicale) | In force | High confidence | |
| US 9,442,114 | Novel Isolated and Purified Strains of Chikungunya Virus and Polynucleotides and Polypeptides Sequences, Diagnostic and Immunogenical Uses Thereof In force · Medium confidence | Institut Pasteur | In force | Medium confidence | |
| US 7,888,041 | In Vitro Diagnostic Method and Kit for an Aspergillus Infection In force · High confidence | Institut Pasteur | In force | High confidence | |
| US 9,005,961 | Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions In force · Medium confidence | Institut Pasteur and Centre National de la Recherche Scientifique | In force | Medium confidence | |
| US 8,124,380 | Glycoconjugates and Their Use as Potential Vaccines Against Infection by Shigella Flexneri Inserm (Institut National de la Sante et de la Recherche Medicale), Institut Pasteur and Centre National de la Recherche Scientifique In force · High confidence | Inserm (Institut National de la Sante et de la Recherche Medicale), Institut Pasteur and Centre National de la Recherche Scientifique | In force | High confidence | |
| US 9,422,548 | Ob-Fold Used as Scaffold for Engineering New Specific Binders In force · Medium confidence | Centre National de la Recherche Scientifique | In force | Medium confidence | |
| US 11,434,585 | Ob-Fold Used as Scaffold for Engineering New Specific Binders In force · Medium confidence | Institut Pasteur and Centre National de la Recherche Scientifique | In force | Medium confidence | |
| US 9,499,799 | Cells and Methodology to Generate Non-Segmented Negative-Strand RNA Viruses In force · Medium confidence | Centre National De La Recherche Scientifique | In force | Medium confidence |
10 of 10 patents shown. Soonest term end first, then patent number.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.